Scott Dreyer
Evp & Chief Commercial Officer at Collegium Pharmaceutical, Inc (COLL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 5SEC | COLLCollegium Pharmaceutical, Inc | Sell Plan | 46,41775,329 held (−38%) | $40.36 | $1.9M | -42.5% |
| Mar 5SEC | COLLCollegium Pharmaceutical, Inc | Sell Plan | 3,55971,770 held (−5%) | $40.99 | $146K | -43.4% |
| Dec 10SEC | COLLCollegium Pharmaceutical, Inc | Sell Plan | 11,125110,088 held (−9%) | $47.89 | $533K | -51.6% |
| Dec 10SEC | COLLCollegium Pharmaceutical, Inc | Sell Plan | 6,475103,613 held (−6%) | $48.66 | $315K | -52.3% |
- Sell
Evp & Chief Commercial Officer Scott Dreyer sold $1.9M of COLL at $40.36 — cuts the stake by 38%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Commercial Officer Scott Dreyer sold $146K of COLL at $40.99 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Commercial Officer Scott Dreyer sold $533K of COLL at $47.89 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp & Chief Commercial Officer Scott Dreyer sold $315K of COLL at $48.66 — pre-scheduled 10b5-1 plan sale.